Almonty's Sangdong Milestone: One Container Shipped, but the Delivery Curve Is Still Unwritten
Published on 10/27/2026 at 09:51 | Editorial boerse-global.de
A single container of tungsten concentrate has left Almonty's Sangdong mine in South Korea bound for a customer — the first shipment from the site in more than 30 years, according to CEO Lewis Black, who announced the departure on Sunday. It is a genuine operational milestone. It is not, on its own, proof of a dependable supply flow, and investors would be wrong to treat it as one.
The distinction matters because the market has recently been handed two very different kinds of news. The first is physical: concentrate has actually moved. The second is analytical: two brokerages have trimmed their price targets while keeping their bullish ratings intact.
Two Targets Cut, Both Ratings Held
Stifel's Brock Cannon lowered his target to US$21 from US$25 on 20 October, citing pushed-back delivery assumptions for Sangdong's first and second phases. He kept his buy recommendation. Oppenheimer's Ian Zaffino had already moved on 15 October, cutting his target to US$19 from US$25 while maintaining an "Outperform" rating.
Neither move amounts to a reversal of faith. Both analysts retained their positive calls and simply marked their expectations down — a signal of tempered assumptions rather than abandonment. Nor does the container shipment contradict them. A first delivery can leave the mine while later volumes are modelled more conservatively, and reading the shipment as a rebuttal of the target cuts would be premature.
Should investors sell immediately? Or is it worth buying Almonty?
Running at Full Throughput Is Not the Same as Selling
Diamond Equity Research, in analysis published roughly a week ago, reported that Sangdong's grinding circuit had reached full throughput, with the mill running about 16 hours a day in early October. That speaks to plant performance and daily operating hours — not to completed sales. Production progress and commercial settlement are separate stages, and conflating them is where investors can go astray.
The same analysis noted that the first vessel had been booked for 24 October 2026. A booking is a logistics step, not evidence of a shipment already made; even after the scheduled date, the original statement remains, in substance, a reservation. An investor day held about a week ago added revised timing expectations for both Sangdong phases, tying operational development to the expected delivery schedule without making the two interchangeable.
Buybacks and a Korean Listing Are Separate Questions
Capital deployment deserves its own hearing. Diamond Equity Research reported buybacks of 2,914,739 shares for approximately US$48 million through the end of September. That is a quantified use of funds — one that can address dilution concerns but says nothing about how quickly Sangdong material reaches customers. A buyback announcement is also not the same as full execution.
Media reports roughly a week ago added talks about a possible additional Korean listing, with Korean depositary receipts floated as one route and the existing foreign listing expected to be retained. Talks about a listing are not a completed capital-markets transaction.
Almonty at a turning point? This analysis reveals what investors need to know now.
A Cautiously Constructive Verdict
The constructive reading: Almonty has hit a concrete milestone, and both analysts stayed positive even as their targets came down. The cautious reading: delivery assumptions have slipped, and one container carries limited evidentiary weight. Yesterday's 4.6% share price gain does nothing to resolve that tension.
The sensible conclusion sits between the two. Almonty deserves credit for restarting shipments from Sangdong after three decades. Greater confidence, though, should come from the deliveries that follow — not from the symbolism of the first one.
Ad
Almonty Stock: New Analysis - 27 October
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
